Commentary

Ethical concerns in the age of an advanced psychopharmacology

Abstract

No Abstract

Tekiner H, Kosar M. The opium poppy as a symbol of sleep in Bertel Thorvaldsen's relief of 1815. Sleep Med. 2016; 19: 123-5.

Rossi M. Homer and Herodotus to Egyptian medicine. Vesalius. 2010; Suppl: 3-5.

Dolan B. Soul searching: a brief history of the mind/body debate in the neurosciences. Neurosurg Focus. 2007; 23(1): E2.

Glannon W. Mind-brain Dualism in psychiatry: ethical implications. Front Psychiatry. 2020; 11: 85.

Peloso PF. Psychiatry in Genoa. Hist Psychiatry. 2004; 15(57 Pt 1): 27-43.

Harris JC. Pinel orders the chains removed from the insane at BicĂȘtre. Arch Gen Psychiatry. 2003; 60(5): 442.

Lopez-Munoz F, Alamo C, Cuenca E, Shen WW, Clervoy P, Rubio G. History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry. 2005; 17(3): 113-35.

Sneader W. The 50th anniversary of Chlorpromazine. Drug News Perspect. 2002; 15(7): 466-71.

Fond G. The praise of the leak: a tribute to Henri Laborit (1914-1995). Tunis Med. 2013; 91(8-9): 487-9.

Laborit H, Huguenard P, Alluaume R. A new vegetative stabilizer; 4560 R.P. Presse Med. 1952; 60(10): 206-8.

Delay J, Deniker P, Harl JM. Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP). Ann Med Psychol (Paris). 1952; 110(2 1): 112-7.

Loomer HP, Saunders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc. 1957; 8: 129-41.

Alamo C. Serendipitous discovery of first two antidepressants. Taiwanese Journal of Psychiatry (Taipei). 2014; 28(2): 67-70.

Shorter E. The history of lithium therapy. Bipolar Disord. 2009; 11(Suppl. 2): 4-9.

Cade JF. Lithium salts in the treatment of psychotic excitement.1949. Bull World Health Organ. 2000; 78(4): 518-20.

Lopez-Munoz F, Baumeister AA, Hawkins MF, Alamo C. The role of serendipity in the discovery of the clinical effects of psychotropic drugs: beyond of the myth. Actas Espanolas de Psiquiatria. 2012; 40(1): 34-42.

Spiegel R. Psychopharmacology: An Introduction, 4th ed. USA: Wiley; 2003, p. 45-49.

Frierson RL, Joshi KG. Malpractice law and psychiatry: an overview. Focus (Am Psychiatr Publ). 2019; 17(4): 332-6.

Whitley R. The antipsychiatry movement: dead, diminishing, or developing? Psychiatric Services. 2012; 63(10): 1039-41.

Kecmanovic D. Postpsychiatry: how to throw out the baby with the bathwater. Psychiatr Danub. 2009; 21(3): 276-82.

Vyshka G, Kazaferi A, Kapo I, Mana T. Forbidden insanity: the systematic denial of mental health issues from a state-run psychiatry. Psychiatr Danub. 2018; 30(4): 385-9.

Tobin JP. Editorial: political abuse of psychiatry in authoritarian systems. Ir J Psychol Med. 2013; 30(2): 97-102.

Lopez-Munoz F, Alamo C, Garcia-Garcia P, Molina JD, Rubio G. The role of psychopharmacology in the medical abuses of the Third Reich: from euthanasia programmes to human experimentation. Brain Res Bull. 2008; 77(6): 388-403.

Carrier F, Banayan D, Boley R, Karnik N. Ethical challenges in developing drugs for psychiatric disorders. Prog Neurobiol. 2017; 152: 58-69.

Sluijs WH. Descending on steps which are never thy own, dissertation and advice concerning support by CORDAID MOMOE of projects for the reform of psychiatry and care for the disabled, and construction of mental health care in Central and Eastern European countries 2002. [cited Dec 2021]; Available from: https://archives.law.virginia.edu/records/mss/81-9s

Lincoln TM, Jung E, Wiesjahn M, Wendt H, Bock T, Schlier B. The impact of negative treatment experiences on persistent refusal of antipsychotics. Compr Psychiatry. 2016; 70: 165-73.

DeVylder JE. Fixity of thinking and the foundations of identity: an argument for the evolutionary adaptiveness of delusions. Early Interv Psychiatry. 2019; 13(3): 720-1.

Fountoulakis KN. Should denialism of mental illness and its treatment be included among conspiracy theories? Eur Arch Psychiatry Clin Neurosci. 2021: 1-3.

Serretti A. The present and future of precision medicine in psychiatry: focus on clinical psychopharmacology of antidepressants. Clin Psychopharmacol Neurosci. 2018; 16(1): 1-6.

Karamanou M, Liappas I, Antoniou Ch, Androutsos G, Lykouras E. Julius Wagner-Jauregg (1857-1940): introducing fever therapy in the treatment of neurosyphilis. Psychiatriki. 2013; 24(3): 208-12.

Turkheimer FE, Selvaggi P, Mehta MA, et al. Normalizing the abnormal: do antipsychotic drugs push the cortex into an unsustainable metabolic envelope? Schizophrenia Bulletin. 2020; 46(3): 484-95.

Dorph Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005; 30:1649-61.

Files
IssueVol 14 (2021) QRcode
SectionCommentary
DOI https://doi.org/10.18502/jmehm.v14i29.8285
Keywords
Antipsychotic drugs Psychopharmacology Ethics Chance discovery

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Vyshka G, Ulqinaku D, Mana T. Ethical concerns in the age of an advanced psychopharmacology. J Med Ethics Hist Med. 2021;14.